These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27156625)

  • 1. Isoniazid-resistant tuberculosis in Iran: A systematic review.
    Javad Nasiri M; Chirani AS; Amin M; Halabian R; Imani Fooladi AA
    Tuberculosis (Edinb); 2016 May; 98():104-9. PubMed ID: 27156625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada.
    Romanowski K; Chiang LY; Roth DZ; Krajden M; Tang P; Cook VJ; Johnston JC
    BMC Infect Dis; 2017 Sep; 17(1):604. PubMed ID: 28870175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014.
    Karo B; Kohlenberg A; Hollo V; Duarte R; Fiebig L; Jackson S; Kearns C; Ködmön C; Korzeniewska-Kosela M; Papaventsis D; Solovic I; van Soolingen D; van der Werf MJ
    Euro Surveill; 2019 Mar; 24(12):. PubMed ID: 30914081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoniazid Resistance and Dosage as Treatment for Patients with Tuberculosis.
    Nagel S; Streicher EM; Klopper M; Warren RM; Van Helden PD
    Curr Drug Metab; 2017; 18(11):1030-1039. PubMed ID: 29086682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid-resistant tuberculosis: a cause for concern?
    Stagg HR; Lipman MC; McHugh TD; Jenkins HE
    Int J Tuberc Lung Dis; 2017 Feb; 21(2):129-139. PubMed ID: 28234075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
    Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
    BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran.
    Doustdar F; Khosravi AD; Farnia P; Masjedi MR; Velayati AA
    Microb Drug Resist; 2008 Dec; 14(4):273-9. PubMed ID: 19090721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current interest of isoniazid in the chemotherapy of tuberculosis in the light of its in vitro activity.
    Ruiz P; Rodríguez-Cano F; Zerolo FJ; Casal M
    Microb Drug Resist; 2003; 9(3):313-6. PubMed ID: 12959411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Beijing and Haarlem genotypes among multidrug-resistant Mycobacterium tuberculosis in Iran: Systematic review and meta-analysis.
    Tarashi S; Fateh A; Jamnani FR; Siadat SD; Vaziri F
    Tuberculosis (Edinb); 2017 Dec; 107():31-37. PubMed ID: 29050769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid derivatives and their anti-tubercular activity.
    Hu YQ; Zhang S; Zhao F; Gao C; Feng LS; Lv ZS; Xu Z; Wu X
    Eur J Med Chem; 2017 Jun; 133():255-267. PubMed ID: 28390957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of drug-resistant tuberculosis in Iran: systematic review and meta-analysis.
    Nasiri MJ; Dabiri H; Darban-Sarokhalil D; Rezadehbashi M; Zamani S
    Am J Infect Control; 2014 Nov; 42(11):1212-8. PubMed ID: 25242634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of tuberculosis among contacts of isoniazid-resistant and isoniazid-susceptible cases.
    Tuberculosis Research Centre, Indian Council of Medical Research (ICMR), Chennai, India
    Int J Tuberc Lung Dis; 2011 Jun; 15(6):782-8. PubMed ID: 21575299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
    Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis.
    Thai PVK; Ha DTM; Hanh NT; Day J; Dunstan S; Nhu NTQ; Kiet VS; Lan NH; Dung NH; Lan NTN; Thuong NT; Lan NN; Liễu PTT; Hồng NT; Điệp ĐC; Thanh NTK; Hội NV; Nghĩa NV; Đại TN; Minh HQ; Thơm NV; Farrar J; Caws M
    BMC Infect Dis; 2018 Mar; 18(1):112. PubMed ID: 29510687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa.
    van der Heijden YF; Karim F; Mufamadi G; Zako L; Chinappa T; Shepherd BE; Maruri F; Moosa MS; Sterling TR; Pym AS
    Int J Tuberc Lung Dis; 2017 Jun; 21(6):670-676. PubMed ID: 28482962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Outcomes with Fluoroquinolone-Containing Regimens for Isoniazid-Resistant Pulmonary Tuberculosis.
    Lee H; Jeong BH; Park HY; Jeon K; Huh HJ; Lee NY; Koh WJ
    Antimicrob Agents Chemother; 2016 Jan; 60(1):471-7. PubMed ID: 26525801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective analysis of isoniazid-monoresistant tuberculosis: among Iranian pulmonary tuberculosis patients.
    Varahram M; Nasiri MJ; Farnia P; Mozafari M; Velayati AA
    Open Microbiol J; 2013; 8():1-5. PubMed ID: 24600483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
    Unissa AN; Dusthackeer VNA; Kumar MP; Nagarajan P; Sukumar S; Kumari VI; Lakshmi AR; Hanna LE
    Tuberculosis (Edinb); 2017 Dec; 107():144-148. PubMed ID: 29050763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, treatment, and outcomes of isoniazid mono-resistant Mycobacterium tuberculosis infections in Alberta, Canada from 2007-2017.
    Edwards BD; Edwards J; Cooper R; Kunimoto D; Somayaji R; Fisher D
    PLoS One; 2020; 15(3):e0229691. PubMed ID: 32155169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.